SPOTLIGHT -
Key opinion leaders in the field of cancer management discuss resistance to the uptake of biomarker testing and precision medicine, with deference to the community setting.
Increased Germline Testing Rates Promote Crucial Breast Cancer Care
Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC
New Approvals Continue to Shift Treatment Landscape in Hematologic Malignancies
Gordan on Growing the Infrastructure for In-House Genomic Testing
Erdafitinib Data in FGFR+ Cholangiocarcinoma Indicates Utility of NGS in Treatment Selection
Biomarkers Clarify Treatment Decisions and Sequencing in Endometrial Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making